RESUMEN
The effects of supramolecular encapsulation on the photophysics and photostability of a highly fluorescent dimeric derivative of 2,6-diacetoxy-9,10-bis(arylethynyl)anthracene (G2) were investigated by single-molecule fluorescence spectroscopy (SMFS). The fluorescence properties of free-G2 and its self-assembled boronic ester encapsulation complex, G2@(Cap)2, were compared in solution and a glassy polymer film. The fluorescence spectral characteristics and theoretical calculations suggest that the environment affects the excited-state conformation and subsequent fluorescence emission of G2@(Cap)2. In particular, in the liquid and polymer environments, G2@(Cap)2 emits a fluorescence photon in the planar and twist conformation, respectively, whereas the fluorescence-emitting conformation of free-G2 is planar in both environments. The luminous conformation differences between free-G2 and G2@(Cap)2 in polymer are reflected in the intersystem crossing (ISC) parameters (the ISC quantum yield and triplet lifetime), as determined by fluorescence autocorrelation analysis. The photobleaching yield revealed a 3-fold enhancement in the photostability of encapsulated G2 (relative to free-G2). Under the SMFS measurement conditions, the photostability of the encapsulation complex was independent of the guest's photostability and appeared to be dominated by the thermal stability of the Cap host molecule.
RESUMEN
For single-molecule fluorescence studies, highly photostable fluorophores are absolutely imperative, because photo-induced degradation (i.e., photobleaching) limits the observation time of individual molecules. Herein, the photophysics and photostability of a highly fluorescent 9,10-bis(phenylethynyl)anthracene derivative (G) and its self-assembled boronic ester encapsulation complex (G@Cap) embedded in a glassy polymer matrix are investigated by single-molecule fluorescence spectroscopy (SMFS). The heterogeneity of the fluorescence emission wavelength and triplet blinking kinetics of the guest G are significantly decreased by supramolecular encapsulation due to conformational restriction and reduced heterogeneity in the local environment. A nearly 10-fold increase in the photostability of G due to encapsulation is quantitatively confirmed by evaluating the photobleaching yields of G and G@Cap. In addition, it is found that the G@Cap is >30-fold more photostable than rhodamine 6G, a widely used fluorescent dye in single-molecule studies. These results demonstrate that the G@Cap can serve as a very bright, long-lasting fluorescent probe for single-molecule studies.
RESUMEN
Idiopathic thrombocytopenic purpura (ITP), an autoimmune hematologic disorder characterized by severe platelet count reduction, can be treated with romiplostim. However, post-marketing safety and effectiveness data for romiplostim in Japan are scarce. This prospective, observational, post-marketing Specified Use-Results Survey evaluated the real-world safety and effectiveness of romiplostim for 2 years. All patients treated with romiplostim during the survey period were eligible. Of the 1622 patients in the safety analysis set, 94.08% (1526/1622) had chronic ITP. The mean single dose of romiplostim was stable after 12 weeks and remained < 6 µg/kg in approximately 70% of patients until 104 weeks. Within 2 years, 14.92% of patients discontinued romiplostim because of adverse events, while 6.47% discontinued because of suspected adverse drug reactions. In contrast, 14.00% of patients discontinued romiplostim because of symptom improvement. Before romiplostim initiation, platelet count was < 2.0 × 104/µL in 60.54% of patients, and the mean platelet count was 2.84 ± 5.76 × 104/µL. Platelet count was 9.19 ± 13.01 × 104/µL after 4 weeks, and remained between 10.34 ± 10.72 and 12.38 ± 12.63 × 104/µL from 8 to 104 weeks of treatment. No specific concerns were revealed regarding the safety and effectiveness of romiplostim in chronic ITP; the findings demonstrated a favorable risk-benefit balance for romiplostim in this population. Trial registration: UMIN000047864 ( www.umin.ac.jp/ctr ).
RESUMEN
A microbial consortium that reductively dechlorinates trichloroethene, cis-1,2-dichloroethene (cis-DCE), and vinyl chloride (VC) to ethene with methanogenesis was enriched from chloroethene-contaminated soil from Japan. Dechlorination activity was maintained for over 4 years. Using quantitative polymerase chain reaction (PCR) and denaturing gradient gel electrophoresis (DGGE) analysis targeting the "Dehalococcoides" 16S rRNA gene, four strains were detected. Their growth and dechlorination activities were classified into two types: one that grows by converting cis-DCE to ethene and the other that grows by converting cis-DCE to VC. Then, the vcrA and bvcA genes encoding cis-DCE/VC reductive dehalogenases were detected. Inhibitors of methanogenesis (2-bromoethanesulfonate) and sulfidogenesis (molybdate) led to accumulation of cis-DCE and of VC respectively. These results suggest that methanogens and sulfate-reducing bacteria can play a significant role in dechlorination by "Dehalococcoides."